Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Heritage Mining's Contact Bay: Two Large Ni-Cu-PGE Mafic-Ultramafic Intrusives (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Resverlogix Ord Shs T.RVX

Alternate Symbol(s):  RVXCF

Healthcare Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSX:RVX)

Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy

Newsfile October 4, 2023

Resverlogix Announces a Favorable Outlook Based on New Cardiovascular Disease Treatment Guidelines for Patients with Type 2 Diabetes

Newsfile August 29, 2023

Resverlogix Announces Warrant Repricing and One-Year Extension

Newsfile June 29, 2023

Resverlogix Announces Voting Results from the 2023 Meeting of Shareholders

Newsfile June 20, 2023

Resverlogix Announces New Insights into the Mechanism of Apabetalone's Cardioprotective Benefit in Chronic Kidney Disease Patients

Newsfile June 12, 2023

Resverlogix Announces One-Year Extension of Debenture

Newsfile March 20, 2023

Resverlogix Announces New Research Highlighting Apabetalone's Potential Benefits in Cardiovascular Disease, Heart Failure, and COVID-19

Newsfile March 2, 2023

Resverlogix (TSX:RVX) focuses drug development on COVID-19

Caroline Egan  September 28, 2022

Resverlogix Confirms Focus on Treatment of Post COVID-19 Conditions

GlobeNewswire September 28, 2022
View More News ››

Opinion & Analysis (TSX:RVX)

Buzz on the Bullboards: Will Cooler Heads Prevail?

Omri Wallach October 3, 2019

'Pivotal Topline Up Next' for Biotech's Phase 3 Cardiac Clinical Trial

Streetwise Reports May 2, 2019

Biotech’s Lead Drug Candidate Targets 'Market with Huge Potential'

Streetwise Reports November 2, 2018

Biotech's shares 'undervalued' and positioned for 'long-term upside potential'

Streetwise Reports December 28, 2017

Biotech receives 'major endorsement from world-leading pharma company'

Streetwise Reports December 21, 2017

Coverage initiated on 'one of the most undervalued biotech companies in Canada'

Streetwise Reports December 8, 2017
View More Opinion ››

Bullboard Posts (TSX:RVX)

Rvx headed

To a penny , Don clearly has nothing ,was, is all the big lie . Time to load up the truck hey . There will be a bucket of tomatoes at the...
Storm23 - August 25, 2023

Great post on Agoracom by fuzzyjr

No fluff , no pulled punches just the truth about this po s  CEO and BOD
Storm23 - July 31, 2023

AGM

Not going to get any material info ,ordinarily they hold the AGM after close but not this time .Prob is nothing to give us .Shorts...
Storm23 - June 5, 2023

Sp by AGM

Be at .05 by the time slippery Don has the AGM at this rate of downward spiral .
Storm23 - May 31, 2023

This is a REALLY BIG STORY.

Clive Maund Technical Analysis
pomme214 - April 6, 2023

RE:RE:For What It's Worth!

Can't comment on Moriarty's assertions, other than to say that these vaccines work EXACTLY by instructing your cells to create...
FredZarfloon - April 4, 2023
View more Bullboard ››

Blue Sky Uranium Corp

Blue Sky Uranium Corp

Blue Sky Uranium Corp. is engaged in uranium discovery in Argentina. The Company is a uranium and vanadium exploration ...
View More »